Month: June 2025

TORONTO, Ontario, Canada and BENGALURU, Karnataka, India, June 27, 2025 (GLOBE NEWSWIRE) — Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), is pleased to announce that Health Canada has granted a Notice of Compliance (NOC) for Yesafili™ (aflibercept), a biosimilar to Eylea® (aflibercept) injection, in vial and prefilled syringe presentations, 2 mg/0.05 mL on June 26, 2025. This approval paves the way for the launch of YESAFILI in Canada, scheduled for July 4, 2025. YESAFILI is the first biosimilar to EYLEA to be approved by Health Canada. YESAFILI is a vascular endothelial growth factor (VEGF) inhibitor indicated for the treatment of:Neovascular (wet) age-related macular degeneration (AMD) Visual impairment due to macular edema secondary...

WATERTOWN, Mass., June 26, 2025 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced the pricing of its underwritten public offering of $250.8 million of shares of its common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock. Kymera is selling 5,044,500 shares of common stock and, in lieu of common stock to certain investors, pre-funded warrants to purchase 655,500 shares of common stock in the offering. The shares of common stock are being sold at a public offering price of $44.00 per share and the pre-funded warrants are being sold at a public offering price of $43.9999 per pre-funded warrant, which represents...

SEATTLE and VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence for smoking cessation, today announced the pricing of an underwritten public offering of 15,000,000 shares of its common stock and accompanying common warrants to purchase up to 15,000,000 shares of common stock. The shares of common stock and accompanying common warrants were offered collectively at a price to the public of $3.00 per share and accompanying common warrant. Achieve has also granted the underwriters a 30-day option to purchase up to an additional 2,250,000 shares of common stock and/or accompanying common warrants to purchase up to an additional...

Ruling provides clarity on the future of master planned Los Angeles County community TEJON RANCH, Calif., June 26, 2025 (GLOBE NEWSWIRE) — Tejon Ranch Co. (NYSE:TRC), (“Tejon” or the “Company”), a diversified real estate development and agribusiness company, today released the following statement in response to the California Court of Appeals’ decision to uphold the Los Angeles County Superior Court’s previous decision regarding the Company’s Centennial development. We disagree with the Court of Appeals’ ruling and importantly note that the decision affirms that the Company prevailed on 20 of the 23 items resolved at the trial court. Furthermore, the ruling does not address any additional issues. In the coming days, we intend to work with Los Angeles County to evaluate how best to advance Centennial in a way that benefits the region...

CALGARY, Alberta, June 26, 2025 (GLOBE NEWSWIRE) — Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), is pleased to announce it has entered into an agreement (the “Marwayne Agreement”) with O’Neill Industries International-Canada Inc. (“O’Neill Canada”) that will result in the transfer of certain wells and other assets located in Marwayne, Alberta, related liabilities, licenses and leases from Acceleware to O’Neill Canada, and the termination of the existing farmout and option agreement dated May 19, 2020 between the Company and O’Neill Canada. O’Neill Canada is the Canadian entity of O’Neill Industries, a US based company active in upstream production and oil field services globally. In exchange for the above noted transfers, Acceleware will receive cash payments and a gross overriding royalty (“GORR”) on future production...

Settlement of Tranche 1 of the Placement for A$18.2m TORONTO and PERTH, Australia, June 26, 2025 (GLOBE NEWSWIRE) — Further to the ASX announcement on 20 June 2025, Cygnus Metals Limited (“Cygnus” or the “Company”) advises that it has issued a total of 211,627,907 fully paid ordinary shares (“Shares”) at A$0.086 each under Tranche 1 of the Placement, raising a total of A$18,200,000 (before costs). The Shares were issued under the Company’s existing capacity under ASX Listing Rules 7.1 (126,702,591) and 7.1A (84,925,316). A further 1,162,790 Shares are intended to be issued under Tranche 2 of the Placement to Non-Executive Director Raymond Shorrocks, or his nominees, subject to receipt of shareholder approval at a general meeting to be held in August 2025. In addition, the Company has issued a total of 306,129 Shares to employees...

VANCOUVER, June 26, 2025 (GLOBE NEWSWIRE) — Fortuna Mining Corp. (NYSE: FSM | TSX: FVI) announces the voting results from its 2025 annual general meeting of shareholders held earlier today. A total of 188,888,907 common shares were represented at the meeting, accounting for 61.54% of Fortuna’s issued and outstanding shares as of the record date. Shareholders voted in favor of all matters of business, including the appointment of auditors and the election of all director nominees listed in the Company’s Management Information Circular dated May 1, 2025. Detailed results of the vote for the election of directors are as follows:Nominee Votes For % For Votes Withheld % WithheldJorge A. Ganoza 159,475,985 99.48 % 831,198 0.52 %David Laing 154,870,542 96.61 % 5,436,641 3.39 %Mario Szotlender 154,344,778 96.28 % 5,962,405 3.72 %David...

Tiburon, CA, June 26, 2025 (GLOBE NEWSWIRE) — FIGX Capital Acquisition Corp. (the “Company”) announced today the pricing of its initial public offering of 13,100,000 units. The units are expected to be listed on The Nasdaq Global Stock Market LLC (“Nasdaq”) and begin trading tomorrow, June 27, 2025, under the ticker symbol “FIGXU.” Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. An amount equal to $10.00 per unit will be deposited into a trust account upon the closing of the offering. Once the securities constituting the units begin separate...